Triple metachronous primary cancer of uterus, colon, and breast cancer

Guanqiao Li, Jiaxi Yao, Tangna Wu, Yaxiong Chen, Zhenping Wang, Yiming Wang, Fen Wang, Rui Zhong, Shi‐Ping YangMedicine 2020 · DOI

TL;DR

This paper presents a rare case of a patient with three distinct primary cancers (uterus, colon, and breast) diagnosed sequentially over 19 years. It also provides the first comprehensive review of similar cases involving breast cancer, highlighting that these "triple primary malignancies" are uncommon, predominantly affect older women, and are associated with a better prognosis when diagnosed at early stages.

What Problem Does This Paper Address?

The paper addresses the rarity and diagnostic challenges of multiple primary malignancies (MPM), specifically focusing on cases involving three or more distinct cancers, with a particular emphasis on those including breast cancer. While synchronous or metachronous diagnoses of two cancers are relatively common, cases with three or more primary tumors are exceptionally rare, with limited literature on their management and prognosis. The authors aim to consolidate existing knowledge by reviewing reported cases and presenting a detailed account of a unique patient's journey, thereby contributing to a better understanding of this complex clinical scenario.

Methods

The study employs a two-pronged approach:

  • Case Report: A detailed clinical narrative of a 67-year-old female patient diagnosed with endometrial cancer (1999), colon cancer (2008), and breast cancer (2018). This involved reviewing her medical history, diagnostic imaging (ultrasound, mammography, CT scans), pathological reports, and treatment outcomes.
  • Literature Review: A systematic review of English-language studies published between January 1990 and December 2019, identifying 23 previous cases of triple or more primary malignancies that included breast cancer. This review focused on patient demographics, cancer types, timing of diagnosis (synchronous vs. metachronous), and outcomes.

Datasets

Not discussed in the paper. The study relies on individual patient case data and published literature rather than specific, curated datasets for training or evaluation.

Key Insights and Ideas

  • Extreme Rarity: Triple or more primary malignancies, especially those including breast cancer, are exceptionally rare. The authors identified only 23 previous cases in a 30-year literature review.
  • Demographic Trends: These complex cases predominantly affect older female patients, with an average age of 64 years in the reviewed literature.
  • Common Cancer Combinations: When breast cancer is involved in triple or more primary malignancies, the most frequent accompanying cancers are those of the colon, uterus, and lung.
  • Prognostic Significance of Stage: A favorable prognosis is strongly associated with early-stage diagnoses for these multiple primary cancers, underscoring the importance of timely detection and treatment.
  • Diagnostic Vigilance: For patients with a history of multiple cancers, even lesions categorized as BI-RADS category 3 (suggesting a low probability of malignancy) warrant careful consideration and potentially biopsy due to the increased underlying risk.

Key Results

  • The case report details a patient who successfully navigated three distinct primary cancers over a 19-year period, with no recurrence or distant metastasis observed at follow-ups ranging from 19 months to 20 years.
  • The literature review identified 23 previous cases of triple or more primary malignancies including breast cancer.
  • Of the reviewed cases, 62.5% were metachronous (diagnosed sequentially) and 37.5% were synchronous (diagnosed at the same time).
  • Colon cancer was the most prevalent primary tumor (8 cases), followed by uterine cancer (7 cases) and lung cancer (5 cases) among the reviewed triple primary malignancies involving breast cancer.
  • Eight of the reviewed cases reported outcomes of death, metastasis, or recurrence, while outcomes for the remaining cases were not specified.

Limitations and Future Work

  • Limited Literature: The primary limitation is the extreme rarity of these cases, which restricts the ability to conduct large-scale statistical analyses or establish definitive treatment guidelines. The authors acknowledge the limited literature and the short follow-up periods in many reported cases.
  • Diagnostic Challenges: Differentiating between a new primary cancer and a metastasis or recurrence of a previous cancer can be challenging, impacting staging and treatment decisions.
  • Treatment Guidelines: There are currently no established guidelines for the diagnosis and treatment of multiple neoplasms, making management complex and individualized.
  • Future Work: The authors implicitly suggest the need for continued case reporting and literature reviews to build a more robust understanding of these rare conditions. Further research could focus on identifying genetic predispositions, environmental factors, and optimal surveillance strategies for patients with a history of multiple cancers. The paper also raises a question about the appropriateness of chemotherapy for stage I colon cancer, suggesting a need for adherence to established guidelines like NCCN.

Summary updated

Abstract

To our knowledge, this is the first review of triple or more primary malignancies including breast cancer. These malignancies occur predominantly in older female patients. The most prevalent tumors of triple or more primary malignancies including breast cancer occur in the colon, uterus, and lung. A favorable prognosis is associated with early-stage malignancies.
BibTeX
@inproceedings{li2020triple,
  author = {Guanqiao Li and Jiaxi Yao and Tangna Wu and Yaxiong Chen and Zhenping Wang and Yiming Wang and Fen Wang and Rui Zhong and Shi‐Ping Yang},
  title = {{Triple metachronous primary cancer of uterus, colon, and breast cancer}},
  booktitle = {Medicine},
  year = {2020},
  doi = {10.1097/md.0000000000021764},
}
Figure